Skip to Main Content

Paper Details

Immunogenicity of High-Dose Egg-Based, Recombinant, and Cell Culture-Based Influenza Vaccines Compared With Standard-Dose Egg-Based Influenza Vaccine Among Health Care Personnel Aged 18-65 Years in 2019-2020.
Open Forum Infect Dis
1
2023
Author NameAffiliation
Brendan FlanneryCenters for Disease Control and Prevention
Kempapura Murthy
Manjusha Gaglani
Manjusha GaglaniTexas A&M University, College of Medicine
  • 1 - 4

Datasets

Release 1.2